课题基金 / 基金详情

BAG1/BAG3比值调控缺血性脑卒中急性期UPS和自噬降解错误折叠蛋白质的机制研究

批准号:
82101372
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
刘夏
依托单位:
学科分类:
脑血管结构、功能异常及相关疾病
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
刘夏

项目摘要

结项摘要

相似基金

相关文献

中文摘要
缺血性脑卒中引起的蛋白质错误折叠及聚集会导致神经元变性及延迟性死亡。泛素蛋白酶体系统(UPS)与自噬是细胞内蛋白质降解的主要途径,既往被认为是两条独立的通路,但越来越多的研究表明它们可以相互影响及互补。申请人前期研究发现错误折叠蛋白质(MP)的产生会随着脑缺血及再灌注时间的延长而增加,如MP未能被及时降解将聚集并导致UPS功能紊乱,机体降解MP的主要途径从UPS向自噬转化,且在此过程中BAG1/BAG3比值明显降低。因此推测在缺血性脑卒中急性期通过上调BAG3或下调BAG1表达以进一步降低BAG1/BAG3比值,促进UPS向自噬转化,减少MP聚集,减轻UPS功能紊乱,从而保护神经元。本项目拟利用BAG3转基因小鼠,采用体内外缺血性脑卒中模型,通过腺病毒载体转基因调控BAG1/BAG3比值,阐明BAG1/BAG3比值对缺血性脑卒中影响的分子机制,为缺血性脑卒中的治疗提供新的靶点及理论依据。
英文摘要
Protein misfolding and aggregation caused by ischemic stroke will lead to neurodegeneration and delayed neuronal death. The ubiquitin-proteasome system (UPS) and autophagy are 2 major protein quality control pathways in eukaryotic cells. They were previously considered to be 2 independent pathways, but now many studies have shown that they can interact and complement the functions of one another. The applicant’s previous research suggested that the production of misfolded proteins (MPs) increased with the prolongation of cerebral ischemia and reperfusion time. If MPs were not degraded in time, it would accumulate and cause UPS dysfunction. The main pathway for the body to degrade MPs switched from UPS to autophagy, and the BAG1/BAG3 ratio decreased significantly during this process. Therefore, it is speculated that by increasing the expression of BAG3 or decreasing the expression of BAG1 in the acute phase of ischemic stroke to further reduce the BAG1/BAG3 ratio will promote the conversion of UPS to autophagy and enhance the degradation of misfolded proteins, then rescues UPS dysfunction, thereby reduce misfolded protein aggregation, and ultimately protect neurons. On this basis, this project intends to utilize BAG3 transgenic mice, and built in vivo and in vitro ischemic stroke models, and then use adenovirus vector transgene to regulate BAG1/BAG3 ratio to observe the effect of BAG1/BAG3 ratio changes after cerebral ischemia, and further explore the molecular mechanism. This project will provide new therapeutic targets for acute ischemic stroke.
缺血性脑卒中是致残致死率最高的脑血管疾病之一,为患者家庭及社会带来了很大的负担,因此深入了解缺血性脑卒中的病理机制、寻找新的药物和治疗手段已成为亟待解决的问题。本项目在前期的研究基础上,通过利用体内大脑中动脉缺血再灌注(MCAO)动物模型和体外氧糖剥夺/复氧模型,采用免疫荧光、免疫共沉淀、WB以及小动物行为学评价等方法,研究调控BAG1/BAG3比值通过促进UPS向自噬转化以减轻UPS功能紊乱在脑缺血急性期起神经保护的关键作用及分子机制。我们发现:在MCAO急性期中,抑制UPS通路活性可以激活自噬作为降解错误折叠蛋白质的通路,从而减轻MCAO造成的脑损伤,而抑制自噬则会加重脑损伤。并且,通过在体内外缺血再灌注模型中上调BAG3蛋白表达,使BAG1/BAG3比值进一步降低,可以在缺血再灌注早期通过激活自噬来降解错误折叠蛋白质,并通过抑制凋亡,来减轻脑损伤。本研究系统阐释了BAG3与缺血性脑卒中神经损伤的相关性及具体机制,以上发现将有助于进一步阐明脑卒中神经损伤的机制,为缺血性脑卒中的治疗提供新的靶点及理论依据。
国内基金
海外基金